13F Data
Security · CUSIP 55414P702

MABVAX THERAPEUTICS

EQUITIES · institutional ownership from 13F filings
13F holders
2
Shares held
616.8K
Value held
$31.0K
New / sold out
1 / 0
Added / reduced
0 / 0
net +582.9K shares

13F holders by quarter

Q1 2018: 11Q2 2018: 15Q3 2018: 2Q4 2018: 2Q1 2019: 1Q2 2019: 2Q3 2019: 0Q3 2021: 1Q4 2021: 1Q1 2022: 0Q2 2022: 1Q3 2022: 1Q4 2022: 0
Q1 2018Q4 2022

Net shares bought by existing holders

Q1 2018: 1.1MQ2 2018: 192.3KQ3 2018: -1.3MQ4 2018: 10.1KQ1 2019: -2.5KQ2 2019: 582.9KQ3 2019: -616.8KQ3 2021: 23Q4 2021: 0Q1 2022: -23Q2 2022: 23Q3 2022: 0Q4 2022: -23
Q1 2018Q4 2022

Top holders · Q2 2019

ManagerSharesValue% of portfolio
Cambridge Investment Research Advisors, Inc.582,855$29.0K0.00%
PANAGORA ASSET MANAGEMENT INC33,958$2.0K0.00%

Biggest buyers

ManagerChangeShares changeChange %
Cambridge Investment Research Advisors, Inc.New+582,855–

Biggest sellers

Nothing to show.